Immersive Virtual Reality for Stroke Motor Rehabilitation
Launched by MINDMAZE SA · Mar 23, 2017
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ischemic or hemorrhagic minor-to-moderate (0\<NIHSS\<16) stroke with hemiparesis and experiencing arm motor difficulties
- • At least 6 months after stroke incident
- • Maximum 4 on the Medical Research Council Scale (MRCS) for shoulder elevation and elbow flexion/extension
- • 18 years and older
- • First ever stroke
- Exclusion Criteria:
- • Participating in another movement treatment study at the time of the present study
- • Severe cognitive impairment (Mini Mental Status Examination score \< 18 points)
- • Orthopedic impairment or visual disorders limiting the treatment
- • Unable to give informed consent form
- • Risk of epileptic seizures
About Mindmaze Sa
MindMaze SA is a pioneering neurotechnology company dedicated to transforming the way neurological disorders are diagnosed and treated. By integrating advanced virtual reality, motion capture, and artificial intelligence, MindMaze develops innovative therapeutic solutions that enhance patient outcomes in rehabilitation and cognitive health. With a strong commitment to research and development, the company collaborates with leading academic institutions and healthcare providers to advance clinical trials and bring cutting-edge therapies to market, ultimately improving the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sion, Valais, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials